| Serial Number | 90602703 |
| Word Mark | HEALTH. ILLUMINATED. |
| Filing Date | Thursday, March 25, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, February 14, 2023 |
| Registration Number | 6981371 |
| Registration Date | Tuesday, February 14, 2023 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 30, 2021 |
| Goods and Services | Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use |
| Goods and Services | Genetic testing services for diagnostic or treatment purposes; genetic testing for medical purposes; genetic counseling; diagnostic services in the field of genetics, namely, the identification of genes that predispose individuals to common diseases and health disorders for diagnostic or treatment purposes; medical testing, namely, providing reference and clinical laboratory tests that detect, classify, analyze, and evaluate gene mutations, gene variants, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and for use in evaluating and selecting therapy or treatment regimens; medical testing services for evaluating and selecting therapy or treatment regimens, prognosing disease, predicting disease progression or disease severity, identifying predisposition to developing disease, evaluating the efficacy or toxicity of medical treatments, and identifying risk factors of disease, molecular profiles associated with successful therapies or treatment regimens, and for classifying disease progression or severity; medical diagnostic testing, monitoring, and reporting services; internet-based health care information services; providing an internet website for medical professionals featuring medical information in the field of hereditary cancer risk assessment and testing; providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment, drug, and dosage levels for patients through the use of data obtained through personalized pharmacogenetic testing, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis and medical and pharmaceutical consultation services related thereto, namely, discussion and interpretation with clients of medical test results and medical analysis related thereto; medical testing services, namely, providing medical tests that measure, analyze, and interpret genes and medications of patients, environmental, and other factors through an algorithm that weighs the contribution of each medication's multiple pathways of absorption, distribution, metabolism, and excretion and each medication's receptor activity, mechanism of action, and pathways of response and then measures the impact of genomic changes across these pathways and across multiple of patients to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection, and treatment options and choices for patients, identify potentially harmful drug interactions, and calculate drug dosage adjustments for patients; and medical information services, namely, preparation and generation of reports for the foregoing medical testing services through proprietary software applications; medical analysis and consultation services which use bioinformatics for diagnostic or treatment purposes; providing objective, evidence-based medical information tailored to each patient's individual genetic profile to enable clinicians to prescribe individually appropriate medications |
| NOT AVAILABLE | "HEALTH" |
| Goods and Services | Medical test kits comprising specimen collection tubes and containers for collecting patient specimens, printed test forms, printed mailing materials, and printed user information inserts used in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testing; blood, urine, and saliva medical specimen collection kits consisting of test tubes and self-mailer, used for health and genetic analysis and diagnostics |
| Goods and Services | Clinical research in the field of genetics directed to the evaluation of genetic variants; clinical research in human genetics; statistical analysis relating to scientific research in the field of human genetics and genetic variation; design and development of statistical algorithms for use in the field of human genetics and evaluation of genetic variations; statistical analysis for determining deleterious genetic variations in the field of human genetics, for scientific research purposes; clinical trial research and laboratory research services for the further purpose of drug discovery services, pharmaceutical research services, pre-clinical medical research screening, and clinical trial, research and evaluation services; biosignatures, genomics, proteomics and pharmacology research services; development of disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening for scientific research purposes, pre-clinical research and trials for pharmaceutical development purposes; and research and development of new diagnostic products and pharmaceutical drug services for others; biochemical analysis services, namely, evaluation of non-genetic biological response to disease, drugs, and the environment; providing temporary use of non-downloadable computer software for customizing, selecting, and ordering health and genetic analysis and diagnostic kits and assays and for accessing, viewing, and storing health and genetic information via electronic, optical, and wireless communication networks; scientific research analysis and consulting services which use bioinformatics; gene and tissue bank services that provide DNA samples for use in future medical and scientific research, medical and scientific educational studies and development of new medical and scientific products and validation thereof |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 30, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | Monday, January 31, 2022 |
| First Use In Commerce Date | Monday, January 31, 2022 |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 30, 2021 |
| Primary Code | 010 |
| First Use Anywhere Date | Monday, January 31, 2022 |
| First Use In Commerce Date | Monday, January 31, 2022 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 30, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, June 23, 2021 |
| First Use In Commerce Date | Wednesday, June 23, 2021 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 30, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | Wednesday, June 23, 2021 |
| First Use In Commerce Date | Wednesday, June 23, 2021 |
| Party Name | Myriad Genetics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84116 |
| Party Name | Myriad Genetics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84108 |
| Party Name | Myriad Genetics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Salt Lake City, UT 84108 |
| Event Date | Event Description |
| Monday, March 29, 2021 | NEW APPLICATION ENTERED |
| Wednesday, June 30, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 6, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, September 8, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 8, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 8, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 25, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, October 25, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, October 25, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, October 25, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, October 25, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 10, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 30, 2021 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 30, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 25, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, January 27, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, January 27, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, January 27, 2022 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, January 27, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 17, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, June 17, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 17, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, June 17, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 17, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 25, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, July 25, 2022 | SOU EXTENSION 1 FILED |
| Monday, July 25, 2022 | SOU EXTENSION 1 GRANTED |
| Wednesday, July 27, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 14, 2022 | TEAS STATEMENT OF USE RECEIVED |
| Wednesday, December 14, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, December 14, 2022 | SOU EXTENSION 2 FILED |
| Wednesday, December 14, 2022 | USE AMENDMENT FILED |
| Wednesday, January 4, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, January 5, 2023 | SOU EXTENSION 2 GRANTED |
| Thursday, January 5, 2023 | STATEMENT OF USE PROCESSING COMPLETE |
| Friday, January 6, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 6, 2023 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Saturday, January 7, 2023 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, February 14, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, February 14, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Wednesday, July 26, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, July 9, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, July 9, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, July 9, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 9, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 9, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |